Previous Close | 1.0000 |
Open | 1.0000 |
Bid | 0.9500 |
Ask | 1.3500 |
Strike | 2.50 |
Expire Date | 2024-05-17 |
Day's Range | 1.0000 - 1.0000 |
Contract Range | N/A |
Volume | |
Open Interest | 260 |
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2024 Earnings Call Transcript May 10, 2024 Relmada Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). LifeSci Advisors: Sergio Traversa – Chief Executive Officer Maged Shenouda – Chief Financial Officer Andrew Cutler – Senior […]
Q1 2024 Relmada Therapeutics Inc Earnings Call
Explore key financial outcomes and strategic updates from Relmada Therapeutics' first quarter of 2024, emphasizing advancements in clinical trials and operational efficiencies.